(Q63990908)

4

0 references

author name string

M Tommasi

1

0 references

D Castelletti

2

0 references

M Pasti

3

0 references

I Lorenzetti

5

0 references

C Pera

7

0 references

G B Ferrara

8

0 references

G Tridente

9

0 references

M Colombatti

Clinical and Experimental Immunology

10

0 references

language of work or name

English

0 references

publication date

September 2001

0 references

published in

0 references

volume

125

0 references

issue

3

0 references

page(s)

391-400

0 references

cites work

Immunotoxins: an update

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Expression of ricin A chain in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

IMGT/HLA database--a sequence database for the human major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Ribosome-inactivating proteins up to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Clinical trials of targeted toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Clinical trials with blocked ricin immunotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Chemistry of peptides associated with MHC class I and class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01525.X

Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis

21 January 2018

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

1 reference

12 December 2020

Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice

1 reference

12 December 2020

Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain

1 reference

12 December 2020

Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells

1 reference

12 December 2020

Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats

1 reference

12 December 2020

The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

1 reference

12 December 2020

Copper staining: a five-minute protein stain for sodium dodecyl sulfate-polyacrylamide gels.

1 reference

12 December 2020

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

1 reference

12 December 2020

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy

1 reference

12 December 2020

An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys

1 reference

12 December 2020

Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.

1 reference

12 December 2020

Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate

1 reference

12 December 2020

Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

1 reference

12 December 2020

Interaction of Staphylococcus aureus toxin "superantigens" with human T cells

1 reference

12 December 2020

Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL

1 reference

12 December 2020

Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial.

1 reference

12 December 2020

The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in rats

1 reference

12 December 2020

Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity.

1 reference

12 December 2020

Suppression of the immune response to immunotoxins with anti-CD4 monoclonal antibodies

1 reference

12 December 2020

Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma

1 reference

12 December 2020

Structure of ricin A-chain at 2.5 A.

1 reference

12 December 2020

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

1 reference

12 December 2020

An altered repertoire of T cell receptor V gene expression by rheumatoid synovial fluid T lymphocytes

1 reference

12 December 2020

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy.

1 reference

12 December 2020

Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies

1 reference

12 December 2020

High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations

1 reference

12 December 2020

Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study

1 reference

12 December 2020

Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer.

1 reference

12 December 2020

T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza mat

1 reference

12 December 2020

Diphtheria toxin-based receptor-specific chimaeric toxins as targeted therapies.

1 reference

12 December 2020

Expression of MHC class I and class II antigens in pancreatic adenocarcinomas

1 reference

12 December 2020

A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma

1 reference

12 December 2020

HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencing

1 reference

12 December 2020

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

1 reference

12 December 2020

HLA-C high resolution typing: analysis of exons 2 and 3 by sequence based typing and detection of polymorphisms in exons 1-5 by sequence specific primers

1 reference

12 December 2020

Solid-phase peptide synthesis

1 reference

12 December 2020